Curehealth Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 02-09-2024
- Paid Up Capital ₹ 4.81 Cr
as on 02-09-2024
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.59 M
as on 02-09-2024
- Satisfied Charges ₹ 20.00 Cr
as on 02-09-2024
- Revenue -56.01%
(FY 2023)
- Profit -87.33%
(FY 2023)
- Ebitda -55.67%
(FY 2023)
- Net Worth 5.18%
(FY 2023)
- Total Assets -2.89%
(FY 2023)
About Curehealth Pharmaceuticals
The Corporate was formerly known as Cureheatlh Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.81 Cr.
The company currently has active open charges totaling ₹0.59 M. The company has closed loans amounting to ₹20.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chhaggan Lal and Anil Kumar serve as directors at the Company.
- CIN/LLPIN
U24230CH2013PTC042680
- Company No.
042680
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Sep 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Curehealth Pharmaceuticals Private Limited offer?
Curehealth Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Injection, Antibiotic Tablets, Capsule & Syrup, Antibacterial Drugs, Anti Infective Agent.
Who are the key members and board of directors at Curehealth Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chhaggan Lal  | Director | 08-Aug-2018 | Current |
| Anil Kumar | Director | 08-Aug-2018 | Current |
Financial Performance of Curehealth Pharmaceuticals.
Curehealth Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 56.01% decrease. The company also saw a substantial fall in profitability, with a 87.33% decrease in profit. The company's net worth moved up by a moderate rise of 5.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Curehealth Pharmaceuticals?
In 2023, Curehealth Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shri Sai Balaji Pharmatech Private LimitedActive 9 years 7 monthsChhaggan Lal and Anil Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 29 Dec 2021 | ₹0.59 M | Open |
Dena Bank Creation Date: 19 Jun 2014 | ₹12.50 Cr | Satisfied |
Bank Of Baroda Creation Date: 11 Nov 2013 | ₹7.50 Cr | Satisfied |
How Many Employees Work at Curehealth Pharmaceuticals?
Curehealth Pharmaceuticals has a workforce of 31 employees as of Sep 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curehealth Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curehealth Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
